Product
Supplier
Encyclopedia
Inquiry
Home > Cosmetic Ingredient > Moisturising Agent > FOXO4-DRI for Sale > Cosmetic Anti-Aging Peptides Foxo4-D-Retro-Inverso (DRI) Peptide Fox04 Dri
Cosmetic Anti-Aging Peptides Foxo4-D-Retro-Inverso (DRI) Peptide Fox04 Dri buy - large image1
Cosmetic Anti-Aging Peptides Foxo4-D-Retro-Inverso (DRI) Peptide Fox04 Dri buy - image1
Cosmetic Anti-Aging Peptides Foxo4-D-Retro-Inverso (DRI) Peptide Fox04 Dri buy - image2
Cosmetic Anti-Aging Peptides Foxo4-D-Retro-Inverso (DRI) Peptide Fox04 Dri buy - image3
Cosmetic Anti-Aging Peptides Foxo4-D-Retro-Inverso (DRI) Peptide Fox04 Dri buy - image4
Cosmetic Anti-Aging Peptides Foxo4-D-Retro-Inverso (DRI) Peptide Fox04 Dri buy - image5
Cosmetic Anti-Aging Peptides Foxo4-D-Retro-Inverso (DRI) Peptide Fox04 Dri buy - image6

Cosmetic Anti-Aging Peptides Foxo4-D-Retro-Inverso (DRI) Peptide Fox04 Dri

26 Inquiries

Unit Price: Get Latest Price
CAS No.:

2460055-10-9

Grade:

Cosmetics Grade

Content:

99%

Port:

xian

Brand:

Fulecare

Packaging:

Double plastic bags plus aluminum foil bag

Price valid (until):

2026-07-15

Company Type:
Trader
Location:
China
Qualification:
Main Products:

Slu-pp-332,BAM 15

  • Product Description

  • Seller Information

  • Inquiry History

  • Description


      Product Detail  


    Shop Factory Supply Bam 15 Powder Bam 15 210302-17-3-Detailed Image 1

    Produsts Name FOXO4-DRI
    CAS No 2460055-10-9
    Purity >99%
    Appearance White  powder
    storage keep in a cool,dark location in a tightly sealed container or cylinder.
    Shelf Life  24 Months

    What is FOXO4-D-Retro-Inverso(DRI) Custom Peptide?
    FOXO4 D-Retro-Inverso peptide, also known as FOXO4 DRI peptide was first reported in 'Targeted Apoptosis of Senescent Cells Restores Tissue Homeostasis in Response to Chemotoxicity and Aging' by Baar et al.

    FOXO4 DRI peptide comprising the amino acid sequence: LTLRKEPASEIAQSILEAYSQNGWANRRSGGKRP, wherein the amino acids in said amino acid sequence are D-amino acid residues. FOXO4 D-Retro-Inverso peptide selectively acts on senescent cells and alleviates impacts of chemotoxicity and aging in mice.

    Application
    FOXO4 D-Retro-Inverso peptide, also known as FOXO4 DRI peptide was first reported in 'Targeted Apoptosis of Senescent Cells Restores Tissue Homeostasis in Response to Chemotoxicity and Aging' by Baar et al.

    FOXO4 DRI peptide comprising the amino acid sequence: LTLRKEPASEIAQSILEAYSQNGWANRRSGGKRP, wherein the amino acids in said amino acid sequence are D-amino acid residues. FOXO4 D-Retro-Inverso peptide selectively acts on senescent cells and alleviates impacts of chemotoxicity and aging in mice.


    Shop Pharmaceutical CAS 1792180-81-4 Ritlecitinib Powder Ritlecitinib-Detailed Image 2 Shop Pharmaceutical CAS 1792180-81-4 Ritlecitinib Powder Ritlecitinib-Detailed Image 3 Shop Pharmaceutical CAS 1792180-81-4 Ritlecitinib Powder Ritlecitinib-Detailed Image 4

    Xi’an Fulecare biotech has high-technique enterprises with 10 years history,dedicate to separation, purification of the natural active ingredients production and sales.

    We also produce international frontier dietary supplements such as granulated powder,solid drinks,tea sachets, capsules and tablets etc.

    We have high grade clean workshop,800 square meters of inspection center equipped with more than 10 sets of HPLC,GC,IR,MASS instruments,these provides a full range of quality assurance to our products

    The company has a perfect quality assurance system.We implement strict quality control standards and have passed the certification for the ISO9001 Quality Management System. The Quality Management Department is equipped with many sets of high performance liquid chromatography (HPLC)instruments, ultraviolet spectrophotometers (UV), several spectropolarimeters, a gas chromatograph (GC), melting point apparatus, and other advanced testing and experimental equipment. We make a detailed division of labor for technology research, and for quality assurance and quality control, so that we can conduct effective and comprehensive quality control in the production process. This also allows us to make comprehensive detection analysis of final products, thus ensuring products quality.

    Our Services


    Shop Pharmaceutical CAS 1792180-81-4 Ritlecitinib Powder Ritlecitinib-Detailed Image 5 Shop Pharmaceutical CAS 1792180-81-4 Ritlecitinib Powder Ritlecitinib-Detailed Image 6

    Packaging & Shipping


    Shop Pharmaceutical CAS 1792180-81-4 Ritlecitinib Powder Ritlecitinib-Detailed Image 7

    DHL Around 3-5 working days
    Fedex Around 4-6 working days
    UPS Around 4-6 working days
    By Air Around 5-7 working days
    By Sea Around 15-30 working days


    Package

    Powder:1kg per bag,25kg per Carton or Drum

    PE bag, glass bottle, or PTFE bottle for inner packing, and aluminum foil bag for outer packing.

    Liquid: glass bottle or PTFE bottle for inner packing, and aluminum foil bag for outer packing.

    Bulk order: Fiber drum or steel drum.

    Payment options T/T,Paypal,Visa,L/C or according to your needs.

    Transportation
     
    UPS,TNT,EMS,Fedex,and so on.According to your location, safe customs clearance, generally delivered to your door within 3-7 days in Europe and the United States.

    Shop Pharmaceutical CAS 1792180-81-4 Ritlecitinib Powder Ritlecitinib-Detailed Image 8 Shop Pharmaceutical CAS 1792180-81-4 Ritlecitinib Powder Ritlecitinib-Detailed Image 9 Shop Pharmaceutical CAS 1792180-81-4 Ritlecitinib Powder Ritlecitinib-Detailed Image 10

    Basic Info
    Product Name:

    FOXO4-DRI

    Other Name:

    FOXO4-DRI;FOXO4 /FOXO4-DRI;FOX04-DRI (D-Retro-Inverso);Fox4-dri

    CAS No.:

    2460055-10-9

    Molecular Weight:

    0

    Color/Form:

    White to off-white

    Categories:

    Moisturising Agent

    Characteristics
  • Seller Information
    Business Type:

    Trader

    Main Products:

    Slu-pp-332,BAM 15

    Location:

    No. 11608, 16th Floor, Unit 1, Building 1, West of Zhangba Liu Road, South Third Ring Road, High tech Zone, Xi'an City, Shaanxi Province

    Payment Terms:

    L/C,TT against B/L draft before shipment,100% TT in advance

    Average lead Time:

    335

    Total Annual Revenue:

    $5 million-$10 million

    Total Employees:

    11-50

    Year of Establishment:

    2025

  • Inquiry History
    26 Inquiries
    Country Product Purchase Quantity Date Posted
    United States

    FOXO4-DRI

    1 G Dec 3, 2023
    United States

    Fox04-dri

    1 G May 20, 2026
    United States

    hot-sale-high-purity-raw-powder-fox04-dri-nad-ghk-cu-mot

    2 PCS Dec 19, 2025
    United States

    foxo4 dri

    10 MT Dec 13, 2025
    United States

    Fox04

    10 MG Oct 30, 2024
    United Kingdom

    High purity foxo4

    1 G May 31, 2026
    United Kingdom

    Foxo4-Dri

    10 MG May 5, 2026
    United States

    Fox04-dri

    100 MG Apr 28, 2026
    Cyprus

    Foxo4 dri

    10 MT Apr 4, 2026
    Cyprus

    FOXO4-DRI

    1 KG Feb 2, 2026
    United States

    FOX04-DRI

    10 PCS Jan 12, 2026
    United States

    FOX04

    10 PCS Jan 12, 2026
    United States

    Foxo4 Dri

    40 MG Sep 15, 2025
    United States

    Fox04 dri

    10 MT Jun 21, 2026
    United States

    FOX04-DRI powder

    10 MT May 29, 2026
    United States

    fox04

    1 G Apr 29, 2026
    United States

    FOXO4-DRI

    1 KG Mar 23, 2026
    United States

    Foxo4-Dri

    Nov 24, 2025
    United States

    FOXO4

    10 PCS Nov 15, 2025
    United States

    Fox04

    1 G Nov 10, 2025
    • 1
    • 2
    • Go to Page Go
    Post an enquiry for this product
pic ×

Scan the QR Code to Share

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.